Robert I Blum sold $482K of Cytokinetics (CYTK)

Executed Mar 9, disclosed Mar 10, 1 day later.

Value, as filed

$482K

7,931 sh × $60.72

Executed

Mar 9

the trade date, as filed

Disclosed

Mar 10

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Robert I Blum President & CEO profile →

Robert I Blum (President & CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $7.3M of CYTK (105,426 sh across 2 lots, as filed), executed Sep 14.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 121 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert I Blum in CYTK

CYTKSALE Cytokinetics, Incorporated $471K
7,500 sh × $62.81
Exec Nov 2
Filed Nov 2 · 6:18 PM ET CYTKSALE Cytokinetics, Incorporated $472K
7,500 sh × $62.88
Exec Oct 12
Filed Oct 13 · 4:00 PM ET CYTKSALE Cytokinetics, Incorporated $491K
7,500 sh × $65.46
Exec Sep 28
Filed Sep 28 · 4:54 PM ET CYTKSALE Cytokinetics, Incorporated $7.3M
105,426 sh across 2 lots
Exec Sep 14
Filed Sep 15 · 5:20 PM ET CYTKSALE Cytokinetics, Incorporated $527K
7,500 sh × $70.24
Exec Aug 31
Filed Aug 31 · 4:55 PM ET CYTKSALE Cytokinetics, Incorporated $576K
7,500 sh × $76.76
Exec Aug 10
Filed Aug 10 · 5:11 PM ET CYTKSALE Cytokinetics, Incorporated $607K
7,500 sh × $80.87
Exec Jul 27
Filed Jul 27 · 4:33 PM ET CYTKSALE Cytokinetics, Incorporated $614K
7,490 sh × $82.02
Exec Jul 13
Filed Jul 14 · 3:34 PM ET